Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Jan;13(1):117–125. doi: 10.1111/j.1365-2125.1982.tb01346.x

Is hypertensive vascular disease reversible?

L J Beilin
PMCID: PMC1401779  PMID: 7066150

Full text

PDF
117

Images in this article

118Figure 1
on p.118
118Figure 2
on p.118
119Figure 3
on p.119
119Figure 4
on p.119
120Figure 5
on p.120

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison P. R., Bleehan N., Brown W., Pickering G. W., Robb-Smith A. H., Russell R. P. The production and resolution of hypertensive vascular lesions in the rabbit. Clin Sci. 1967 Aug;33(1):39–51. [PubMed] [Google Scholar]
  2. Beilin L. J., Garcia R., Blackwell E. Vascular ionic composition and blood pressure changes in experimental renal hypertension. Clin Sci. 1969 Jun;36(3):387–399. [PubMed] [Google Scholar]
  3. Beilin L. J., Goldby F. S., Mohring J. High arterial pressure versus humoral factors in the pathogenesis of the vascular lesions of malignant hypertension. Clin Sci Mol Med. 1977 Feb;52(2):111–117. doi: 10.1042/cs0520111. [DOI] [PubMed] [Google Scholar]
  4. DOYLE A. E. Electrocardiographic changes in hypertension treated by methonium compounds. Am Heart J. 1953 Mar;45(3):363–381. doi: 10.1016/0002-8703(53)90148-3. [DOI] [PubMed] [Google Scholar]
  5. DUSTAN H. P., SCHNECKLOTH R. E., CORCORAN A. C., PAGE I. H. The effectiveness of long-term treatment of malignant hypertension. Circulation. 1958 Oct;18(4 Pt 1):644–651. doi: 10.1161/01.cir.18.4.644. [DOI] [PubMed] [Google Scholar]
  6. Dunn F. G., Bastian B., Lawrie T. D., Lorimer A. R. Effect of blood pressure control on left ventricular hypertrophy in patients with essential hypertension. Clin Sci (Lond) 1980 Dec;59 (Suppl 6):441s–443s. doi: 10.1042/cs059441s. [DOI] [PubMed] [Google Scholar]
  7. FREIS E. D., ROSE J. C., PARTENOPE E. A., HIGGINS T. F., KELLEY R. T., SCHNAPER H. W., JOHNSON R. L. The hemodynamic effects of hypotensive drugs in man. III. Hexamethonium. J Clin Invest. 1953 Dec;32(12):1285–1298. doi: 10.1172/JCI102857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fisher C. M. Cerebral miliary aneurysms in hypertension. Am J Pathol. 1972 Feb;66(2):313–330. [PMC free article] [PubMed] [Google Scholar]
  9. Folkow B. The fourth Volhard lecture: cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension. Clin Sci Mol Med Suppl. 1978 Dec;4:3s–22s. doi: 10.1042/cs055003s. [DOI] [PubMed] [Google Scholar]
  10. GIESE J. ACUTE HYPERTENSIVE VASCULAR DISEASE. 2. STUDIES ON VASCULAR REACTION PATTERNS AND PERMEABILITY CHANGES BY MEANS OF VITAL MICROSCOPY AND COLLOIDAL TRACER TECHNIQUE. Acta Pathol Microbiol Scand. 1964;62:497–515. doi: 10.1111/apm.1964.62.4.497. [DOI] [PubMed] [Google Scholar]
  11. Garner A., Ashton N. Pathogenesis of hypertensive retinopathy: a review. J R Soc Med. 1979 May;72(5):362–365. doi: 10.1177/014107687907200510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. George C. F., Breckenridge A. M., Dollery C. T. Value of routine electrocardiography in hypertensive patients. Br Heart J. 1972 Jun;34(6):618–622. doi: 10.1136/hrt.34.6.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldby F. S., Beilin L. J. How an acute rise in arterial pressure damages arterioles. Electron microscopic changes during angiotensin infusion. Cardiovasc Res. 1972 Sep;6(5):569–584. doi: 10.1093/cvr/6.5.569. [DOI] [PubMed] [Google Scholar]
  14. Goldby F. S., Beilin L. J. Relationship between arterial pressure and the permeability of arterioles to carbon particles in acute hypertension in the rat. Cardiovasc Res. 1972 Jul;6(4):384–390. doi: 10.1093/cvr/6.4.384. [DOI] [PubMed] [Google Scholar]
  15. Goldby F. S., Beilin L. J. The evolution and healing of arteriolar damage in renal-clip hypertension in the rat. An electron microscope study. J Pathol. 1974 Nov;114(3):139–148. doi: 10.1002/path.1711140306. [DOI] [PubMed] [Google Scholar]
  16. Jennings G. L., Esler M. D., Korner P. I. Effect of prolonged treatment on haemodynamics of essential hypertension before and after autonomic block. Lancet. 1980 Jul 26;2(8187):166–169. doi: 10.1016/s0140-6736(80)90059-8. [DOI] [PubMed] [Google Scholar]
  17. KINCAID-SMITH P., McMICHAEL J., MURPHY E. A. The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Q J Med. 1958 Jan;27(105):117–153. [PubMed] [Google Scholar]
  18. Khatri I., Gottdiener J., Notargiacomo A., Freis E. Effect of therapy on left ventricular function in hypertension. Clin Sci (Lond) 1980 Dec;59 (Suppl 6):435s–439s. doi: 10.1042/cs059435s. [DOI] [PubMed] [Google Scholar]
  19. Kincaid-Smith P. Renal pathology in hypertension and the effects of treatment. Br J Clin Pharmacol. 1982 Jan;13(1):107–115. doi: 10.1111/j.1365-2125.1982.tb01345.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lundgren Y. Regression of structural cardiovascular changes after reversal of experimental renal hypertension in rats. Acta Physiol Scand. 1974 Jun;91(2):275–285. doi: 10.1111/j.1748-1716.1974.tb05683.x. [DOI] [PubMed] [Google Scholar]
  21. MASSON G. M., McCORMACK L. J., DUSTAN H. P., CORCORAN A. C. Hypertensive vascular disease as a consequence of increased arterial pressure; quantitative study in rats with hydralazine-treated renal hypertension. Am J Pathol. 1958 Sep-Oct;34(5):817–833. [PMC free article] [PubMed] [Google Scholar]
  22. PICKERING G. W., WRIGHT A. D., HEPTINSTALL R. H. The reversibility of malignant hypertension. Lancet. 1952 Nov 15;2(6742):952–956. doi: 10.1016/s0140-6736(52)92200-9. [DOI] [PubMed] [Google Scholar]
  23. Ramalho P. S., Dollery C. T. Hypertensive retinopathy. Caliber changes in retinal blood vessels following blood-pressure reduction and inhalation of oxygen. Circulation. 1968 Apr;37(4):580–588. doi: 10.1161/01.cir.37.4.580. [DOI] [PubMed] [Google Scholar]
  24. Safar M. E., Peronneau P. A., Levenson J. A., Toto-Moukouo J. A., Simon A. C. Pulsed Doppler: diameter, blood flow velocity and volumic flow of the brachial artery in sustained essential hypertension. Circulation. 1981 Feb;63(2):393–400. doi: 10.1161/01.cir.63.2.393. [DOI] [PubMed] [Google Scholar]
  25. Sen S., Tarazi R. C., Bumpus F. M. Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res. 1977 Sep;11(5):427–433. doi: 10.1093/cvr/11.5.427. [DOI] [PubMed] [Google Scholar]
  26. Sivertsson R., Hansson L. Effects of blood pressure reduction on the structural vascular abnormality in skin and muscle vascular beds in human essential hypertension. Clin Sci Mol Med Suppl. 1976 Dec;3:77s–79s. doi: 10.1042/cs051077s. [DOI] [PubMed] [Google Scholar]
  27. TOBIAN L., REDLEAF P. D. Ionic composition of the aorta in renal and adrenal hypertension. Am J Physiol. 1958 Feb;192(2):325–330. doi: 10.1152/ajplegacy.1958.192.2.325. [DOI] [PubMed] [Google Scholar]
  28. Weiss L. Long-term treatment with antihypertensive drugs in spontaneously hypertensive rats (SHR). Effects on blood pressure, survival rate and cardiovascular design. Acta Physiol Scand. 1974 Jul;91(3):393–408. doi: 10.1111/j.1748-1716.1974.tb05694.x. [DOI] [PubMed] [Google Scholar]
  29. Wolinsky H. Effects of hypertension and its reversal on the thoracic aorta of male and female rats. Morphological and chemical studies. Circ Res. 1971 Jun;28(6):622–637. doi: 10.1161/01.res.28.6.622. [DOI] [PubMed] [Google Scholar]
  30. Wolinsky H. Long-term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes. Morphological and chemical studies. Circ Res. 1972 Mar;30(3):301–309. doi: 10.1161/01.res.30.3.301. [DOI] [PubMed] [Google Scholar]
  31. Yamori Y., Tarazi R. C., Ooshima A. Effect of beta-receptor-blocking agents on cardiovascular structural changes in spontaneous and noradrenaline-induced hypertension in rats. Clin Sci (Lond) 1980 Dec;59 (Suppl 6):457s–460s. doi: 10.1042/cs059457s. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES